{
    "xml": "<topic id=\"PHP97408\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/progynova-ts\" basename=\"progynova-ts\" title=\"Progynova TS\">\n<title>Progynova<tm tmtype=\"reg\"/> TS</title>\n<topic id=\"PHP97637\" outputclass=\"indicationsAndDose\" rev=\"1.11\" parent=\"/clinical-medicinal-product-information/progynova-ts\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>\n<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By transdermal application</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8239;patch once weekly continuously, alternatively apply 1&#8239;patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>Progynova TS 50</i>, subsequently adjust according to response, women receiving <i>Progynova TS 100</i> patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP97714\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/clinical-medicinal-product-information/progynova-ts\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients should be advised on the application of Progynova<tm tmtype=\"reg\"/> TS patches.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP97408",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/progynova-ts",
    "basename": "progynova-ts",
    "title": "Progynova TS",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Menopausal symptoms",
                        "html": "Menopausal symptoms"
                    },
                    {
                        "textContent": "Osteoporosis prophylaxis",
                        "html": "Osteoporosis prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "transdermal application"
                    ],
                    "textContent": "By transdermal application",
                    "html": "By transdermal application"
                },
                "adult": [
                    {
                        "textContent": "Apply 1 patch once weekly continuously, alternatively apply 1 patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with Progynova TS 50, subsequently adjust according to response, women receiving Progynova TS 100 patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis.",
                        "html": "<p>Apply 1&#8239;patch once weekly continuously, alternatively apply 1&#8239;patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>Progynova TS 50</i>, subsequently adjust according to response, women receiving <i>Progynova TS 100</i> patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis.</p>"
                    }
                ]
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients should be advised on the application of Progynova TS patches.",
                "html": "<p>Patients should be advised on the application of Progynova<tm tmtype=\"reg\"/> TS patches.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}